Australia - inglese - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - cetirizine hydrochloride, quantity: 1 mg/ml - oral liquid - excipient ingredients: propylene glycol; sodium benzoate; potassium sorbate; purified water; sucralose; sorbitol solution (70 per cent) (crystallising); sodium citrate dihydrate; citric acid; flavour - seasonal allergic rhinitis: cetirizine is indicated for the relief of symptoms associated with seasonal allergic rhinitis (hay fever) in adults and children aged 1-12 years. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing and redness of theeyes. ,perennial allergic rhinitis: cetirizine is indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children aged 1-12,years. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing. chronic idiopathicurticaria: ,cetirizine is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 1-12 years. it significantly reduces the occurrence, severity and duration of hives and markedly reduces pruritus. as with other antihistamines, patients should be advised to seek medical advice about the possibility that their urticaria is associated with ingestion of certain foods.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - cetirizine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose; magnesium stearate; titanium dioxide; hypromellose; macrogol 3350 - for use in the treatment of seasonal allergic rhinitis in adults and children 12 years of age and older.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - cetirizine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; croscarmellose sodium; microcrystalline cellulose; magnesium stearate; titanium dioxide; hypromellose; macrogol 3350 - seasonal allergic rhinitis: for the relief of symptoms associated with seasonal allergic rhinitis (hay fever) in adults and children aged 6 years and over. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing and redness of the eyes. ,perennial allergic rhinitis: for the relief of symptoms associated with perennial allergic rhinitis in adults and children aged 6 years and over. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing. ,chronic idiopathic urticaria: for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 6 years and over. it significantly reduces the occurrence, severity and duration of hives and markedly reduces pruritus. as with other antihistamines, patients should be advised to seek medical advice about the possibility that their urticaria is associated with ingestion of certain foods.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - cetirizine hydrochloride, quantity: 5 mg - tablet, chewable - excipient ingredients: betadex; lactose monohydrate; silicified microcrystalline cellulose; sucralose; magnesium stearate; maize starch; mannitol; flavour - seasonal allergic rhinitis: relief of symptoms associated with seasonal allergic rhinitis (hay fever) in adults and children aged 6 years & over. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing and redness of the eyes.

Giappone - inglese - すりの適正使用協議会 RAD-AR Council, Japan

glaxosmithkline k.k. - cetirizine hydrochloride - dry syrup, white to faintly grayish white

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

pharmabroker sales ltd - cetirizine hydrochloride 5mg;  ; pseudoephedrine hydrochloride 120mg - modified release tablet - active: cetirizine hydrochloride 5mg   pseudoephedrine hydrochloride 120mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry white y-1-7000

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

pharmabroker sales ltd - cetirizine hydrochloride 5mg;  ; pseudoephedrine hydrochloride 120mg - modified release capsule - 5mg/120mg - active: cetirizine hydrochloride 5mg   excipient: gelatin lactose monohydrate magnesium stearate maize starch opadry white y-1-7000 povidone purified talc active: pseudoephedrine hydrochloride 120mg excipient: ammonio methacrylate copolymer dibutyl phthalate gelatin maize starch methacrylic acid copolymer purified talc stearic acid sucrose

Egitto - inglese - EDA (Egyptian Drug Authority)

ucb-belgium - tablet - 10 mg

Egitto - inglese - EDA (Egyptian Drug Authority)

ucb-belgium - tablet - 10 mg

Egitto - inglese - EDA (Egyptian Drug Authority)

ucb-belgium - syrup - 1 mg/ml